The potential antioxidant activity of 2,3-dihydroselenophene, a prototype drug of 4-aryl-2,3-dihydroselenophenes  by Schumacher, Ricardo F. et al.
Bioorganic & Medicinal Chemistry 19 (2011) 1418–1425Contents lists available at ScienceDirect
Bioorganic & Medicinal Chemistry
journal homepage: www.elsevier .com/locate /bmcThe potential antioxidant activity of 2,3-dihydroselenophene, a prototype
drug of 4-aryl-2,3-dihydroselenophenes
Ricardo F. Schumacher, Alisson R. Rosário, Ana C. G. Souza, Carmine I. Acker, Cristina W. Nogueira,
Gilson Zeni ⇑
Laboratório de Síntese, Reatividade, Avaliação Farmacológica e Toxicológica de Organocalcogênios, CCNE, UFSM, Santa Maria, Rio Grande do Sul, CEP 97105-900, Brazil
a r t i c l e i n f oArticle history:
Received 17 November 2010
Revised 4 January 2011
Accepted 5 January 2011
Available online 11 January 2011
Keywords:
Radical
Oxidative stress
Antioxidant activity
Selenophenes
Reactive oxygen species0968-0896  2011 Elsevier Ltd.
doi:10.1016/j.bmc.2011.01.005
⇑ Corresponding author. Tel.: +55 55 3220 8140; fa
E-mail address: gzeni@pq.cnpq.br (G. Zeni).
Open access under the Ea b s t r a c t
Here we present our results in palladium cross-coupling reaction of aryl boronic acids with 4-iodo-2,
3-dihydroselenophene derivatives. The cross-coupled products were obtained in satisfactory yields. A
dehydrogenation of4,5-diphenyl-2,3-dihydroselenophene was activated by DDQ and the 2,3-diarylselen-
ophene was obtained in good yield. Regarding the antioxidant activity, the selenophene derivative 3awas
effective in counteracting lipid and protein oxidation as well as scavenging ABTS radical. The ﬁndings of
the present study indicate that 3a is a prototype for future drug development programs to treat disorders
mediated by reactive oxygen species.
 2011 Elsevier Ltd. Open access under the Elsevier OA license.1. Biochemistry
Oxidative stress is characterized by an increased concentration
of intracellular oxidizing species, such as reactive oxygen species
(ROS) and is often accompanied by the loss of antioxidant defense
capacity.1 It is well known that excess ROS attack many organs,
and induce oxidative damage directly to critical biological mole-
cules, such as lipoproteins, proteins and nucleotides, causing lipid
peroxidation, and protein oxidation. Metabolic oxidative stress has
been implicated, directly or indirectly, in the development of dis-
eases and degenerative processes, including inﬂammation, cancer,
dementia and physiological aging.2 Moreover, oxidative stress also
plays a central role in liver pathologies.3 Antioxidant pharmaco-
therapy in various forms has emerged as a mean to minimize the
biomolecular damage caused by attack of ROS on vital constituents
of living organisms.4 Therefore, there is a great interest in looking
for new organoselenides, such as functionalized selenophene
rings,5 which could represent a good pharmacological alternative
to counteract oxidative stress.6
2. Chemistry
The palladium-catalyzed cross-coupling reactions of aryl
halides or triﬂates with boronic acids, commonly referred to
Suzuki–Miyaura reactions, are a powerful, versatile, and popularx: +55 55 3220 8998.
lsevier OA license.tool for selective construction of carbon–carbon bonds.7 The palla-
dium-catalyzed Suzuki–Miyaura cross-coupling reaction of aryl
halides with boronic acids and esters has become a common and
convenient synthetic method in organic chemistry for biaryl com-
pounds.8 Many examples of Suzuki coupling reactions, between
heterocyclic halides and phenyl boronic acids, have appeared in
the literature over the past two decades,9 being the key stage in
the synthesis of many currently interesting heterocycle-incorpo-
rated compounds.10 More recently, signiﬁcant advances have been
made in the use of organoboron reagents as coupling partners in a
number of palladium-mediated carbon–carbon bond formation.
Among them, the use of potassium organotriﬂuoroborates, as the
organoboron coupling partner, has some advantages in comparison
to boronic acids and boronic esters, such as be more nucleophilic,
stable in the air, crystalline as solids, and easily prepared.11
Chalcogenophene heterocycles (S, Se, and Te) and their deriva-
tives have numerous uses in the ﬁelds of biochemistry, physical or-
ganic chemistry, materials chemistry, and organic synthesis. For
example, selenophene oligomers are compounds of current inter-
est because many of them show photoenhanced biological activi-
ties12 and crystalline polymerizations.13
Thus, a wide variety of oligomers and related chalcogen com-
pounds, including mixed thiophene-pyrrole oligomers, have been
synthesized mainly with the expectation of obtaining excellent
precursor compounds for molecular devices and electroconductive
polymers.14 In addition, chalcogenophenes are widely studied
agents with a diverse array of biological effects, these include anti-
oxidant,15 antinociceptive,16 and antiinﬂammatory properties17 as
R
SeBu
I2 (1.1 equiv)
CH2Cl2 Se
I
R
1a-h
(67 - 93%)
R=C6H5, 4-MeC6H4, 4-ClC6H4, 4-MeOC6H4,
Sen-Bu, SCH3, CH(OH)C5H11, H
Scheme 2.
Table 1
Optimization conditionsa
Entry [Pd] Base Solvent Yield (%)
1 PdCl2 K2CO3 DMF 25
2 Pd(PPh3)2Cl2 K2CO3 DMF 30
3 Pd(OAc)2 K2CO3 DMF 10
4 Pd(PPh3)4 K2CO3 DMF 78
5 Pd(PPh3)4 Na2CO3 DMF 46
6 Pd(PPh3)4 Cs2CO3 DMF 57
7 Pd(PPh3)4 KOH DMF 10
8 Pd(PPh3)4 K3PO4 DMF 60
9 Pd(PPh3)4 K2CO3 Dioxane 72
10 Pd(PPh3)4 K2CO3 Toluene 77
11 Pd(PPh3)4 K2CO3 CH3CN 74
12 Pd(PPh3)4 K2CO3 THF 50
13 Pd(PPh3)4 K2CO3 DMF 25b
14 Pd(PPh3)4 K2CO3 DMF 63c
15 Pd(PPh3)4 K2CO3 DMF 40d
16 Pd(PPh3)4 K2CO3 DMF 70e
17 Pd(PPh3)4 K2CO3 DMF 55f
a The reaction was performed using 1a (0.25 mmol), 2a (1.5 equiv), [Pd]
(2 mol %), base (2 equiv), H2O (0.4 mL) and solvent (2 mL).
b Using 1 mol % of Pd(PPh3)4.
c Using 5 mol % of Pd(PPh3)4.
d Reaction at 70 C.
e Reaction at 110 C.
f Reaction performed using 2 equiv of 2a.
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these heterocycles have been synthesized and their chemistry has
attracted a good deal of interest and activity from a variety of
standpoints, such as structures, stereochemistry, reactivities, and
applications to organic synthesis.19 The electrophilic cyclization
of alkynes bearing, an organochalcogen moiety, is a powerful ap-
proach to the preparation of several functionalized chalcogenoph-
enes with high regioselectivity,20 particularly, when one considers
that there are many ways to transform selectively the resulting
halogen, sulfur, selenium, and tellurium functionalities into a great
number of interesting substituted heterocycles.
During the course of our research program aiming at structure–
activity relationship studies in order to evaluate the pharmacology
activity of heterocycles,5,15–17 we required the synthesis of 2,
3-dihydroselenophenes having a substituted aromatic ring at the
4-position. Since the Suzuki reaction has proven to be successful
for the selective arylation of heterocyles,21 it was of interest to ex-
plore this reaction to obtain 4-aryl-2,3-dihydroselenophene deriv-
atives. To our knowledge this methodology has not been explored
and we now wish to report the application of 4-iodo-2,3-dihyd-
roselenophenes 1a–h as substrates on the cross-coupling reaction
with boronic acids 2a–j in the presence of a palladium salt to ob-
tain 4-aryl-2,3-dihydroselenophenes 3a–r (Scheme 1).
3. Results and discussion
The starting 4-iodo-2,3-dihydroselenophenes 1a–h were read-
ily available by using the electrophilic cyclization protocol of homo
propargyl selenides. The treatment of these selenides with iodine
(1.1 equiv) in CH2Cl2 at room temperature lead to the formation
of the 4-iodo-2,3-dihydroselenophenes 1a–h. By this methodology
a wide range of substituents at 5-position could be used and the
starting materials were obtained in isolated yields of 67–93%
(Scheme 2).22
Our initial studies have focused on the development of an opti-
mum set of reaction conditions. In this way, 4-iodo-5-phenyl-2,3-
dihydroselenophene 1a and phenyl boronic acid 2a were used as
standard substrates. Thus, a mixture of 4-iodo-2,3-dihydroselen-
ophene 1a (0.25 mmol), phenyl boronic acid 2a (0.375 mmol) were
reacted with different palladium catalysts, bases and solvents, the
results are shown in Table 1.
As shown in Table 1, both Pd(0) and Pd(II) catalysts with differ-
ent ligands were tested, the best result was obtained using
Pd(PPh3)4 2 mol % which gave the desired product 3a in 78% yield
(Table 1, entry 4). It is important to note that when the amount of
catalyst was changed from 2 to 5 mol % and using less than 2 mol %
of Pd(PPh3)4, a decrease in the yields of the coupling products were
observed (Table 1, entries 13 and 14). The presence of base was
crucial for a clean, high-yielding reaction. For this reason, in our
experiments we investigated the inﬂuence of other bases. As listed
in Table 1, when the reaction was carried out using Na2CO3,
Cs2CO3, KOH, and K3PO4 the target product was obtained in poor
to moderated yields (Table 1, entries 5–8). The best result was ob-
tained using K2CO3, which gave the desired product 3a in 78% yield
(Table 1, entry 4). Regarding the inﬂuence of the solvents, all sol-
vents tested (dioxane, toluene, CH3CN, and THF) gave the product
in good yields (Table 1, entries 9–12), however, the highest yield
was achieved using a mixture of DMF/H2O, which furnished theSe
I
R1 Se
Ar
R1
Ar B(OH)2
[Pd], Base
Solvent,100 °C
1a-h 2a-j 3a-r
Scheme 1.desired product 3a in 78% yield (Table 1, entry 4). It is also impor-
tant to mention that when the temperature of the Suzuki reaction
was changed from 100 to 70 C or 110 C the yields of the coupling
products were not improved (Table 1, entries 15 and 16).
Thus, careful analysis of theoptimized reactions revealed that the
optimum conditions for this coupling reaction were found to be the
use of 4-iodo-5-phenyl-2,3-dihydroselenophene 1a (0.25 mmol)
and phenyl boronic acid 2a (1.5 equiv), Pd(PPh3)4 (2 mol %), in
DMF/H2O, at 100 C. In this condition we are able to prepare 4,5-di-
phenyl-2,3-dihydroselenophene 3a in 78% (Scheme 3).
In order to demonstrate the efﬁciency of this protocol, we ex-
plored the generality of our method extending the conditions to
other 4-iodo-2,3-dihydroselenophene compounds 1a–h with dif-
ferent arylboronic acids 2a–j and the results are summarized in
Table 2. First, to determine the real inﬂuence of the substituent
at aromatic ring of boronic acids, we kept the substrate 1a invari-
able. The results revealed that the reaction is not sensitive to the
electronic effect of the aromatic ring attached in the boron atom.
For example, arylboronic acid bearing an electron-donating
group methoxyl at the para position gave a very similar yield than
the arylboronic acid bearing an electron-withdrawing group CF3
(Table 2, entry 3 vs 8). Differentiation in the reactivity betweenSe
I
Ph Se
Ph
Ph
Ph B(OH)2
Pd(PPh3)4 (2 mol%)
K2CO3 (2 equiv)
DMF / H2O, 100°C
1a 2a 3a (78 %)
Scheme 3.
Table 2
Products of cross-coupling reactiona
Entry 3-Iodo-dihydroselenophene 1 Boronic acid 2 Product 3 Yieldb (%)
1 Se
I
1a
B(OH)2
2a
Se Ph
3a
77
2 1a
B(OH)2
2b
Se Ph
3b
74
3 1a
B(OH)2MeO
2c
Se Ph
OMe
3c
50
4 1a
B(OH)2
2d
Se Ph
3d
75
5 1a B(OH)2
2e
Se Ph
3e
70
6 1a
B(OH)2Cl
2f
Se Ph
Cl
3f
67
7 1a
B(OH)2Br
2g
Se Ph
Br
3g
60
8 1a
B(OH)2
F3C
2h Se Ph
CF3
3h
50
9 1a
B(OH)2
O2N
2i Se Ph
NO2
3i
77
10 1a
B(OH)2
Me(O)C
2j
Se Ph
O
Me
3j
66
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Table 2 (continued)
Entry 3-Iodo-dihydroselenophene 1 Boronic acid 2 Product 3 Yieldb (%)
11
Se
I
1b
2b
Se
3k
80
12
Se
I
OMe
1c
2b
Se
OMe
3l
67
13
Se
I
Cl
1d
2b
Se
Cl
3m
64
14
Se
I
SeBu
1e 2b
Se SeBu
3n
71
15
Se
I
SMe
1f 2b
Se SMe
3o
62
16
Se
I
C5H11
OH
1g
2b
Se
C5H11
OH
3p
70
17
Se
I
H
1h 2b
Se H
3q
42
18 1h 2e
Se H
Cl
3r
60
a The reaction was performed using 1 (0.25 mmol), 2 (1.5 equiv), Pd(PPh3)4 (2 mol %), K2CO3 (2 equiv) in DMF/H20 (5:1) at 100 C.
b Isolated yields.
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experiments described in Table 2, entries 6 and 7, which provide
only the Suzuki product, without any homo-coupling product. To
the best of our knowledge, aryl halogen could react with boronic
acids in the presence of palladium catalysts to afford biaryl prod-
ucts.23 In our case, the halogen substituent was not affected. We
also found that steric effects had a little inﬂuence on the couplingreaction. Aryl boronic acid containing a methyl group at the ortho
position or naphthyl boronic acid, gave slightly difference in the
yield of product 3 compared to arylboronic acids no substituted
(Table 2, entry 1 vs 4 and 5). In an attempt to broaden the scope
of our methodology, the possibility of performing the reaction with
other 4-iodo-2,3-dihydroselenophene was also investigated. Then
the substrates 1b–d, which have aryl group in the 5-position of
Figure 2. Effect of 3a on protein carbonyl content induced by SNP in rat liver
homogenate. Data are reported as mean ± SD of four independent experiments.
Results were reported as nmol carbonyl content/mg protein. (⁄) Denotes p <0.05 as
compared to the control tube (one-way ANOVA/Duncan). (#) Denotes p <0.05 as
compared to the induced tube (one-way ANOVA/Duncan). ‘I’ means the tube sample
containing SNP to induce protein carbonylation
1422 R. F. Schumacher et al. / Bioorg. Med. Chem. 19 (2011) 1418–1425the selenophene ring containing both electron-donating and elec-
tron-withdrawing groups, were also cross-coupled efﬁciently,
under the same reaction conditions (Table 2, entries 11–13).
Additionally, the substrates 1e and 1f, which have an additional
chalcogen atom in the 5-position, gave the Suzuki products in good
yields (Table 2, entries 14 and 15). These results are highly useful
in synthesis, particularly when one considers that there are many
ways to transform the resulting chalcogen functionalities into
other substituents.24 Finally, it is worth mentioning that, our reac-
tion system was also suitable for the cross-coupling of 4-iodo-2,3-
dihydroselenophene having either propargyl alcohol or with none
substituents in the 5 position, giving the desired products in good
yields (Table 2, entries 16–18).
Since selenophene derivatives exhibit a broad range of biologi-
cal activities and applications as intermediates in organic synthe-
sis, we wondered if it would be possible to prepare selenophenes
directly from 2,3-dihydroselenophenes. Recently, it was reported
that 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) is a useful pro-
moter for the oxidation of 2,3-dihydro-thiophene25 or -furan26 to
aromatic thiophene or furan. Gratifyingly, we found that the reac-
tion of 2,3-dihydroselenophene 3a (1 equiv) with DDQ (2 equiv) in
toluene at 90 C gave the selenophene 4a in 86% yield (Scheme 4).
4. Pharmacology
Since the results from our research group and others have
demonstrated that the introduction of a substituent group into
unsaturated system of organochalcogen does not alter the pharma-
cological activity,6 compound 3a, a non substituted selenophene,
was chosen as a prototype drug to evaluate the antioxidant poten-
tial of 4-aryl-2,3-dihydroselenophenes.
Excessive production of ROS is known to affect lipid membrane
through lipid peroxidation and also oxidized proteins. Oxidative
stress can be accessed through the direct quantiﬁcation of ROS,
antioxidants, and by the measurement of oxidative stress end
products. In this study, we investigated the antioxidant effects ofDDQ (2 equiv)
Toluene, 90 oCSe
Ph
Ph
3a
Se
Ph
Ph
4a - 86%
Scheme 4.
Figure 1. Effect of 3a on TBARS levels induced by SNP in rat liver homogenate. Data
are reported as mean ± SD of four independent experiments. Results were reported
as nmol MDA (malondialdehyde)/mg protein. (⁄) Denotes p <0.05 as compared to
the control tube (one-way ANOVA/Duncan). (#) Denotes p <0.05 as compared to the
induced tube (one-way ANOVA/Duncan). ‘I’ means the tube sample containing SNP
to induce lipid peroxidation.compound 3a on protein and lipid oxidation induced by sodium
nitroprusside (SNP). SNP is a good chemical inducer of lipid perox-
idation,27 since it releases NO in tissue preparations.28 This radical
easily produces peroxynitrite (ONOO), together with superoxide
anion radical (O2
), thus leading to lipid peroxidation and produc-
tion of additional free radicals.29 One product of lipid peroxidation
is malondialdehyde, which can be determined by measuring the
amount of thiobarbituric acid reactive species.30 As shown in
Fig. 1, compound 3a at concentrations equal or greater than
30 lM was effective in protecting against lipid peroxidation
induced by SNP in rat liver homogenate. The calculated IC50 valueFigure 3. Scavenging activity of compound 3a on ABTS radicals. Data are reported
as mean ± SD of four independent experiments. Results were reported as percent-
age of the control. (⁄) Denotes p <0.05 as compared to the control tube (one-way
ANOVA/Duncan).
Se
Ph
Ph
Se Ph GSH
1/2 GSSG + RHR
R
Ph
Scheme 5.
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ing a potential antioxidant activity.
A high level of ROS may result in protein oxidation, leading to
the production of carbonyl groups. Consequently, the determina-
tion of carbonyl content in proteins can be used as a biomarker
of oxidative protein damage.31 Oxidatively modiﬁed proteins in-
duced by SNP were signiﬁcantly reduced by compound 3a at con-
centrations equal or greater than 10 lM (Fig. 2). The calculated IC50
value was 61 lM. Taken together, these results indicate that
compound 3a was effective in counteracting lipid and protein
oxidation.
In addition, 3a was investigated as a compound able to quench
the ABTS radical. Stable radical ABTS has been widely used for the
determination of primary antioxidant activities of pure antioxidant
compounds, plant and fruit extracts, and foods materials.32 Com-
pound 3a showed a signiﬁcant ABTS radical-scavenging activity
at concentrations equal or higher than 30 lM. Although the scav-
enging activity of 3a did not outperform ascorbic acid (Fig. 3),
the activity of 3a is better than diphenyl diselenide, a well known
antioxidant containing selenium.33
Since the selenium atom has a great ability to stabilize radical in
the alpha position34 and higher stability of a tertiary radical inter-
mediate if compared to the possibility of a radical formation in the
2 position, we proposed the mechanism depicted in Scheme 5 to
explain the antioxidant activity of compound 3a. The catalytic cy-
cle shows dangerous radical species adding to the double bond
from selenenophene ring and regeneration by thiol reduction of
the corresponding 2,3-dihydroselenophene radical.
5. Conclusion
In summary, we have explored the Suzuki–Miyaura cross-cou-
pling reaction of 4-iodo-2,3-dihydroselenophene derivatives with
several aryl boronic acids in the presence of catalytic amount of
Pd(PPh3)4 and established a new route to obtain highly substituted
2,3-dihydroselenophene compounds in good to excellent yields.
The reaction of compound 2,3-dihydroselenophene 3a with DDQ
afforded the selenophene derivatives 4a in 86% yield. The ﬁndings
of the present study indicate that 3a is a prototype for future drug
development programs to treat disorders mediated by reactive
oxygen species.6. Experimental
Proton nuclear magnetic resonance spectra (1H NMR) were ob-
tained at 200 MHz on a DPX-200 NMR spectrometer or at 400 MHz
on a DPX-400 NMR spectrometer. Spectra were recorded in CDCl3
solutions. Carbon-13 nuclear magnetic resonance spectra (13C
NMR) were obtained either at 50 MHz on a DPX-200 NMR spec-
trometer or at 100 MHz on a DPX-400 NMR spectrometer. Spectra
were recorded in CDCl3 solutions. Column chromatography was
performed using Merck Silica Gel (230–400 mesh). Thin layer chro-
matography (TLC) was performed using Merck Silica Gel GF254,
0.25 mm thickness. For visualization, TLC plates were either placed
under ultraviolet light, or stained with iodine vapor, or acidic van-
illin. Most reactions were monitored by TLC for disappearance of
starting material. MS spectra were determined using a Shimadzu
GC–MS-2010P. Elemental analyses were performed on a Vario EL
III elemental analysis instrument.
6.1. General procedure for the cross-coupling reaction
To a solution of appropriate 4-iodo-2,3-dihydroselenophene
(0.25 mol) in DMF (2 mL) was added Pd(PPh3)4 (0.0057 g,
2 mol %) and boronic acid (0.375 mmol) under argon. After asolution of K2CO3 (0.5 mmol, 0.069 g) in H2O (0.4 mL) was added.
The mixture was then heated at 100 C. After the required time,
the reaction was cooled to rt, diluted with ethyl acetate (20 mL),
and washed with brine (2  20 mL). The organic phase was sepa-
rated, dried over MgSO4, and concentrated under vacuum. The res-
idue was puriﬁed by ﬂash chromatography on silica gel using
hexane and ethyl acetate as eluents.
6.1.1. Selected spectral and analytical data for 4,5-diphenyl-2,3-
dihydroselenophene (3a)
Yield 0.055 g (78%). 1H NMR (400 MHz, CDCl3): d 7.23–7.05 (m,
10H), 3.49–3.44 (m, 2H), 3.38–3.34 (m, 2H). 13C NMR (100 MHz,
CDCl3): d 137.9, 136.8, 134.0, 133.4, 129.3, 127.1, 128.07, 128.0,
127.4, 126.3, 45.3, 23.3. MS (relative intensity) m/z: 283 (100),
202 (41), 176 (30), 167 (20), 126 (23), 100 (20). Anal. Calcd for
C16H14Se C, 67.37; H, 4.95. Found: C, 67.51; H, 5.01.
6.1.2. 5-Phenyl-4-o-tolyl-2,3-dihydroselenophene (3d)
Yield 0.056 g (75%). 1H NMR (400 MHz, CDCl3): d 7.14–7.07 (m,
9H), 3.42–3.38 (m, 2H), 3.32–3.38 (m, 2H), 2.07 (s, 3H). 13C NMR
(100 MHz, CDCl3): d 138.5, 136.5, 135.6, 135.1, 132.7, 130.2,
128.8, 128.3, 127.8, 127.1, 127.0, 125.8, 46.4, 23.8, 19.7. MS (rela-
tive intensity) m/z: 299 (100), 219 (20), 205 (65), 191 (47), 164
(24), 128 (21), 91 (38). HRMS calcd for C17H16Se [M+Na]+:
323.0315. Found: 323.0321.
6.1.3. 4-(4-Bromophenyl)-5-phenyl-2,3-dihydroselenophene
(3g)
Yield 0.054 g (60%). 1H NMR (400 MHz, CDCl3): d 7.27–7.18 (m,
7H), 6.94–6.90 (m, 2H), 3.46–3.33 (m, 4H). 13C NMR (100 MHz,
CDCl3): d 136.8, 136.5, 134.8, 132.6, 131.1, 129.6, 129.2, 128.3,
127.7, 120.0, 45.0, 23.3. MS (relative intensity) m/z: 363 (15), 359
(100), 279 (13), 201 (47), 167 (27), 149 (21), 127 (22), 100 (32).
HRMS calcd for C16H13BrSe [M+Na]+: 386.9264. Found: 386.9272.
6.1.4. 4,5-Di(p-tolyl)-2,3-dihydroselenophene (3k)
Yield 0.062 g (80%). 1H NMR (400 MHz, CDCl3): d 7.12–7.10 (m,
2H), 6.98–6.93 (m, 6H), 3.45–3.40 (m, 2H), 3.34–3.30 (m, 2H), 2.26
(s, 3H), 2.24 (s, 3H). 13C NMR (100 MHz, CDCl3): d 137.1, 135.8,
135.2, 134.0, 133.3, 132.5, 129.1, 128.8, 128.6, 127.9, 45.4, 23.0,
21.1, 21.0. MS (relative intensity) m/z: 314 (100), 233 (20), 218
(36), 202 (21), 182 (29), 141 (12), 115 (19). HRMS calcd for
C18H18Se [M+Na]+: 337.0471. Found: 337.0483.
6.1.5. 5-(4-Chlorophenyl)-4-p-tolyl-2,3-dihydroselenophene
(3m)
Yield 0.053 g (64%). 1H NMR (200 MHz, CDCl3): d 7.24–7.12 (m,
4H), 7.01–6.92 (m, 4H), 3.50–3.31 (m, 4H), 2.27 (s, 3H). 13C NMR
(100 MHz, CDCl3): d 136.4, 135.5, 134.9, 134.7, 133.0, 131.0,
130.6, 128.8, 128.4, 127.9, 45.4, 23.4, 21.1. MS (relative intensity)
m/z: 333 (100), 280 (14), 218 (37), 202 (35), 189 (23), 131 (14).
HRMS calcd for C17H15ClSe [M+Na]+: 356.9925. Found: 356.9930.
6.1.6. 5-(Butylselenyl)-4-p-tolyl-2,3-dihydroselenophene (3n)
Yield 0.063 g (71%). 1H NMR (200 MHz, CDCl3): d 7.25–7.11 (m,
4H), 3.37–3.25 (m, 4H), 2.81 (t, J = 7.2 Hz, 2H), 2.33 (s, 3H), 1.66
(qui, J = 7.3 Hz, 2H), 1.35 (sext, J = 7.3 Hz, 2H), 0.88 (t, J = 7.2 Hz,
3H). 13C NMR (100 MHz, CDCl3): d 139.5, 136.6, 135.3, 128.7,
127.7, 117.1, 44.5, 32.6, 28.9, 24.8, 22.7, 21.2, 13.5. MS (relative
intensity) m/z: 359 (100), 300 (31), 221 (98), 142 (90), 128 (71),
114 (83), 91 (18). HRMS calcd for C15H20Se2 [M+Na]+: 382.9793.
Found: 382.9803.
6.1.7. 4-p-Tolyl-2,3-dihydroselenophene (3q)
Yield 0.023 g (42%). 1H NMR (400 MHz, CDCl3): d 7.26–7.24 (m,
2H), 7.11–7.09 (m, 2H), 6.93 (t, J = 1.7 Hz, 1H), 3.40 (t, J = 8.1 Hz,
1424 R. F. Schumacher et al. / Bioorg. Med. Chem. 19 (2011) 1418–14252H), 3.18 (t, J = 8.1 Hz, 2H), 2.31 (s, 3H). 13C NMR (100 MHz, CDCl3):
d 139.9, 136.4, 129.1, 125.2, 116.5, 63.9, 38.7, 24.8, 21.1. MS (rela-
tive intensity) m/z: 223 (100), 208 (19), 143 (64), 128 (93), 115
(61), 91 (17). HRMS calcd for C11H12Se [M+Na]+: 247.0002. Found:
247.0014.
6.2. General procedure for the aromatization with DDQ
To a solution of dihydroselenophene 3a (0.25 mmol) in toluene
(3 mL), DDQ (2 equiv) was added. The resulting solution was stir-
red at 90 C for the desired time. The reaction was diluted with
ethyl acetate (30 mL) and washed with aqueous NH4Cl (3 
10 mL). After drying the organic phase over anhydrous MgSO4,
the solvent was removed under reduced pressure and the residue
puriﬁed by ﬂash chromatography on silica gel using hexane as
eluent.
6.2.1. Selected spectral and analytical data for 2,3-diphenyl-
selenophene (4a)
Yield 0.06 g (86%). 1H NMR (200 MHz, CDCl3): d 7.95 (d,
J = 5.7 Hz, 1H), 7.43 (d, J = 5.7 Hz, 1H), 7.27–7.18 (m, 10H). 13C
NMR (100 MHz, CDCl3): d 144.8, 139.8, 137.5, 136.3, 133.7, 129.3,
129.2, 128.9, 128.3, 128.2, 127.1, 126.7. MS (relative intensity)
m/z: 283 (91), 268 (22), 202 (100), 189 (17), 176 (16), 101 (27).
HRMS calcd for C16H12Se [M+Na]+: 307.0002. Found: 307.0010.
6.3. Biochemistry assay
Animals: Male adult albino Wistar rats (200–300 g) from our
own breeding colony were used. The animals were kept on a sep-
arate animal room, in a 12 h light/dark cycle, at a room tempera-
ture of 22 ± 2 C, with free access to food (Guabi, RS, Brazil) and
water. The animals were used according to the guidelines of the
Committee on Care and Use of Experimental Animal Resources,
Federal University of Santa Maria, Brazil.
(a) Thiobarbituric acid reactive species (TBARS) were used as a
measure of lipid peroxidation as described by.30 Rats were
euthanized and liver tissue was rapidly removed. Tissue
was homogenized in 50 mM Tris–HCl, pH 7.4 (1:10, w/v)
and centrifuged at 3000g. The low-speed supernatant (S1)
was separated and used for lipid peroxidation assay. An ali-
quot of 100 ll of S1 was incubated at 37 C for 1 h in the
presence of compound 3a at different concentrations
(1–100 lM). TBARS production was stimulated by the incu-
bation of tissues with 50 lM SNP. The absorbance was mea-
sured at 532 nm. Trolox was used as a positive control.
Results were reported as nmol MDA (malondialdehyde)/mg
protein.
(b) Carbonyl content was assayed as described by Levine.35
Brieﬂy, the liver homogenate was diluted 1:8 (v/v) and
incubated 2 h with compound 3a at different concentrations
(1–100 lM) and SNP (50 lM). Then, 1 mL of aliquot was
mixed with 200 ll 10 mM 2,4-dinitrophenylhydrazine
(DNPH) or 200 ll 2 M HCl. After incubation at room temper-
ature for 1 h in a dark ambient, 500 ll of denaturing buffer
(150 mM sodium phosphate buffer, pH 6.8, containing 3%
SDS), 1.5 mL of heptane (99.5%) and 1.5 mL of ethanol
(99.8%) were sequentially added. The tubes were mixed with
vortex agitation for 40 s and centrifuged for 15 min. Next,
the protein isolated from the interface was washed two
times with 1 mL of ethyl acetate/ethanol 1:1 (v/v) and
suspended in 1 mL of denaturing buffer. The absorbance
was measured at 370 nm. Trolox was used as a positive
control. Results were reported as carbonyl content (nmol/
mg protein).(c) The determination of the ABTS radical scavenging effect of
the compound 3a was performed according to the method
of Re,36 with some modiﬁcations. Initially, the ABTS radical
was generated by reacting 7 mM ABTS solution in water
with 140 mM potassium persulfate in the dark for 12–16 h.
In the day of the assay, the pre-formed ABTS radical solution
was diluted 1:88 in potassium phosphate buffer, pH 7.0.
Brieﬂy, ABTS radical was added to a medium containing
the compound 3a at different concentrations (1–100 lM).
The media were incubated for 30 min at 25 C. The decrease
in absorbance was measured at 734 nm. Ascorbic acid was
used as a positive control. Results are expressed as percent-
age of the blank (without compound).
Acknowledgments
We are grateful to FAPERGS (PRONEX-10/0005-1), CAPES
(SAUX) and CNPq (CNPq/INCT-catalise) for the ﬁnancial support.
CNPq is also acknowledged for the fellowships.References and notes
1. (a) Arteel, G. E.; Sies, H. Environ. Toxicol. Pharmacol. 2001, 10, 153; (b) Santos, O.
S.; Saraiva, D. F.; Costa, D. C. F.; Scofano, H. M.; Alves, P. C. C. Exp. Brain Res.
2007, 177, 347.
2. Ren, J. X.; Yang, L. Q.; Liu, J. Q.; Su, D.; You, D. L.; Liu, C. P.; Zhang, K.; Luo, G. M.;
Mu, Y.; Yan, G. L.; Shen, J. C. Arch. Biochem. Biophys. 2001, 25, 250.
3. Vitaglione, P.; Morisco, F.; Caporaso, N.; Fogliano, V. Crit. Rev. Food Sci. Nutr.
2004, 44, 575.
4. (a) Day, B. J. Drug Discovery Today 2004, 9, 557; (b) Mecklenburg, S.; Collins, C.
A.; Döring, M.; Burkholz, T.; Abbas, M.; Fry, F. H.; Pourzand, C.; Jacob, C.
Phosphorus, Sulfur Silicon 2008, 183, 863.
5. (a) Wilhelm, E. A.; Jesse, C. R.; Roman, S. S.; Nogueira, C. W.; Savegnago, L. Exp.
Mol. Pathol. 2009, 87, 20; (b) Wilhelm, E. A.; Jesse, C. R.; Bortolatto, C. F.;
Nogueira, C. W.; Savegnago, L. Brain Res. Bull. 2009, 79, 281.
6. (a) Nogueira, C. W.; Rocha, J. B. T. J. Braz. Chem. Soc. 2010, 21, 2055; (b)
Nogueira, C. W.; Zeni, G.; Rocha, J. B. T. Chem. Rev. 2004, 104, 6255; (c) Prigol,
M.; Wilhelm, E. A.; Schneider, C. C.; Nogueira, C. W. Chem. Biol. Interact. 2008,
176, 129; (d) Rosa, R. M.; Guecheva, T. N.; de Oliveira, I. M.; Braga, A. L.;
Henriques, J. A. P. J. Braz. Chem. Soc. 2010, 21, 2119; (e) Pinton, S.; Luchese, C.;
Nogueira, C. W. Biol. Trace Elem. Res. doi:10.1007/s12011-010-8645-x.
7. (a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457; (b) Suzuki, A. Pure Appl.
Chem. 1985, 57, 1749; (c) Suzuki, A. Pure Appl. Chem. 1991, 63, 419; (d) Suzuki,
A. Pure Appl. Chem. 1994, 66, 213; (e) Suzuki, A. J. Organomet. Chem. 1999, 576,
147; (f) Oh-e, T.; Miyaura, N.; Suzuki, A. J. Org. Chem. 1993, 58, 2201; (g)
Gronowitz, S.; Hornfeldt, A. B.; Kristjansson, V.; Musil, T. Chem. Scripta 1986, 26,
305; (h) Goering, B. K. Ph.D. Dissertation, Cornell University, 1995.
8. (a) Suzuki, A. InMetal-catalyzed Cross-coupling Reactions; Diederich, F., Stang, P.
J., Eds.; Wiley-VCH: Weinheim, 1998; (b) Lloyd-Williams, P.; Giralt, E. Chem.
Soc. Rev. 2001, 30, 145; (c) Buchanan, J. G.; Sable, H. Z. In Selective Organic
Transformations; Thyagarajan, B. S., Ed.; Wiley-Interscience: New York, 1972;
Vol. 2, pp 1–95.
9. (a) Stanforth, S. P. Tetrahedron 1998, 54, 263; (b) Cailly, T.; Fabis, F.; Legay, R.;
Oulyadi, H.; Rault, S. Tetrahedron 2007, 63, 71; (c) Sicre, C.; Alonso-Gomez, J. L.;
Cid, M. M. Tetrahedron 2006, 62, 11063; (d) Schnurch, M.; Flasik, R.; Khan, A. F.;
Spina, M.; Mihovilovic, M. D.; Stanetty, P. Eur. J. Org. Chem. 2006, 15, 3283.
10. Billingsley, K. L.; Anderson, K. W.; Buchwald, S. L. Angew. Chem., Int. Ed. 2006,
45, 3484.
11. (a) Molander, G. A.; Ellis, N. Acc. Chem. Res. 2007, 40, 275; (b) Molander, G. A.;
Petrillo, D. E.; Landzberg, N. R.; Rohanna, J. C.; Biolatto, B. Synlett 2005, 1763;
(c) Molander, G. A.; Figueroa, R. Aldrichim. Acta 2005, 38, 49; (d) Molander, G.
A.; Felix, L. A. J. Org. Chem. 2005, 70, 3950; (e) Molander, G. A.; Yun, C. S.;
Ribagorda, M.; Biolatto, B. J. Org. Chem. 2003, 68, 5534; (f) Molander, G. A.;
Biolatto, B. J. Org. Chem. 2003, 68, 4302; (g) Molander, G. A.; Katona, B. W.;
Machrouhi, F. J. Org. Chem. 2002, 67, 8416; (h) Molander, G. A.; Reviro, M. R.
Org. Lett. 2002, 4, 107.
12. (a) Ismail, M. A.; Boykin, D. W.; Stephens, C. E. Tetrahedron Lett. 2006, 47, 795;
(b)Chemistry and Biology of Naturally-occurring Acetylenes and Related
Compounds; Lam, J., Breteler, H., Arnason, T., Hansen, L., Eds.; Elsevier:
Amsterdam, 1988.
13. (a) Nakayama, J.; Konishi, T.; Hoshino, M. Heterocycles 1988, 27, 1731; (b)
Kuroda, M.; Nakayama, J.; Hoshino, M.; Furusho, N.; Kawata, T.; Ohba, S.
Tetrahedron 1993, 49, 3735.
14. Okutan, M. M.; Yerli, Y.; San, S. E.; Yılmaz, F.; Günaydın, O.; Durak, M. Synth.
Met. 2007, 157, 368.
15. Meotti, F. C.; Silva, D. O.; Santos, A. R. S.; Zeni, G.; Rocha, J. B. T.; Nogueira, C. W.
Environ. Toxicol. Pharmacol. 2003, 15, 37.
R. F. Schumacher et al. / Bioorg. Med. Chem. 19 (2011) 1418–1425 142516. Gonçales, C. E. P.; Araldi, D.; Panatieri, R. B.; Rocha, J. B. T.; Zeni, G.; Nogueira, C.
W. Life Sci. 2005, 76, 2221.
17. (a) Zeni, G.; Lüdtke, D. S.; Nogueira, C. W.; Panatieri, R. B.; Braga, A. L.; Silveira,
C. C.; Stefani, H. A.; Rocha, J. B. T. Tetrahedron Lett. 2001, 42, 8927; (b) Zeni, G.;
Nogueira, C. W.; Panatieri, R. B.; Silva, D. O.; Menezes, P. H.; Braga, A. L.;
Silveira, C. C.; Stefani, H. A.; Rocha, J. B. T. Tetrahedron Lett. 2001, 42, 7921.
18. (a) Srivastava, P. C.; Robins, R. K. J. Med. Chem. 1983, 26, 445; (b) Streeter,
D. G.; Robins, R. K. Biochem. Biophys. Res. Commun. 1983, 115, 544; (c)
Kirsi, J. J.; North, J.; McKernan, P. A.; Murray, B. K.; Canonico, P. G.;
Huggins, J. W.; Srivastava, P. C.; Robins, R. K. Antimicrob. Agents Chemother.
1983, 24, 353.
19. (a) Rosário, A. R.; Schumacher, R. F.; Gay, B. M.; Menezes, P. H.; Zeni, G.
Eur. J. Org. Chem. 2010, 5601; (b) Stein, A. L.; Alves, D.; da Rocha, J. T.;
Nogueira, C. W.; Zeni, G. Org. Lett. 2008, 10, 4983; (c) Schumacher, R. F.;
Alves, D.; Brandão, R.; Nogueira, C. W.; Zeni, G. Tetrahedron Lett. 2008, 49,
538; (d) Alves, D.; dos Reis, J. S.; Luchese, C.; Nogueira, C. W.; Zeni, G.
Eur. J. Org. Chem. 2008, 377; (e) Bui, C. T.; Flynn, B. L. J. Comb. Chem.
2006, 8, 163.
20. (a) Alves, D.; Luchese, C.; Nogueira, C. W.; Zeni, G. J. Org. Chem. 2007, 72, 6726;
(b) Stein, A. L.; da Rocha, J.; Menezes, P. H.; Zeni, G. Eur. J. Org. Chem. 2010, 705;
(c) Alves, D.; Prigol, M.; Nogueira, C. W.; Zeni, G. Synlett 2008, 6, 914; (d)
Kesharwani, T.; Shilpa, A.; Worlikar, S. A.; Larock, R. C. J. Org. Chem. 2006, 71,
2307; (e) Larock, R. C.; Dawei, Y. Tetrahedron Lett. 2001, 42, 6011.
21. Barancelli, D. A.; Alves, D.; Prediger, P.; Stangherlin, E. C.; Nogueira, C. W.; Zeni,
G. Synlett 2008, 119.
22. Schumacher, R. F.; Rosário, A. R.; Souza, A. C. G.; Menezes, P. H.; Zeni, G. Org.
Lett. 2010, 12, 1952.23. (a) Arvela, R. K.; Leadbeater, N. E. Org. Lett. 2005, 7, 2101; (b) LeBlond, C. R.;
Andrews, A. T.; Sowa, J. R.; Sun, Y. Org. Lett. 2001, 3, 1555.
24. (a) Perin, G.; Lenardão, E. J.; Jacob, R. G.; Panatieri, R. B. Chem. Rev. 2009, 109,
1277; (b) Silveira, C. C.; Braga, A. L.; Vieira, A. S.; Zeni, G. J. Org. Chem. 2003, 68,
662.
25. (a) Lee, H. S.; Kim, S. H.; Kim, J. N. Tetrahedron Lett. 2009, 50, 6480; (b) Flynn, B.
L.; Flynn, G. P.; Hamel, E.; Jung, M. K. Bioorg. Med. Chem. Lett. 2001, 11, 2341.
26. (a) Pohmakotr, M.; Issaree, A.; Sampaongoen, L.; Tuchinda, P.; Reutrakul, V.
Tetrahedron Lett. 2003, 44, 7937; (b) Bellur, E.; Ilia Freifeldb, I.; Langer, P.
Tetrahedron Lett. 2005, 46, 2185.
27. Rauhala, P.; KhaldiI, A.; Mohanakumar, K. P.; Chiueh, C. C. Free Radical Biol. Med.
1998, 24, 1065.
28. Bates, J. N.; Baker, M. T.; Guerra, R.; Harrison, D. G. Biochem. Pharmacol. 1991,
42, 157.
29. Beckman, J. S.; Beckman, T. W.; Chen, J.; Marshall, P. A.; Freeman, B. A. Proc.
Natl. Acad. Sci. 1990, 87, 1620.
30. Ohkawa, H.; Ohishi, H.; Yagi, K. Anal. Biochem. 1979, 95, 351.
31. Reznick, A. Z.; Packer, L. Methods Enzymol. 1994, 233, 357.
32. Chen, C. W.; Ho, C. T. J. Food Lipids 1995, 2, 35.
33. Luchese, C.; Nogueira, C. W. J. Pharm. Pharmacol. 2010, 9, 1146.
34. Reich, H. J.; Willis, W. W. J. Org. Chem. 1980, 45, 5227.
35. Levine, L. R.; Garland, D.; Oliver, C. N.; Amici, A.; Climent, I.; Lenz, A. G.; Ahn, B.
W.; Shaltiel, S.; Stadtman, E. Methods Enzymol. 1990, 186, 464.
36. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M. Free Radical Biol.
Med. 1999, 26, 1231.
